Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study
Sponsor: Centre Hospitalier Universitaire de Besancon
Summary
This study aims to assess the incidence of atrial fibrillation (AF), documented using data recorded by an implantable Holter monitoring device (Reveal Linq, Medtronic) within 2 years after percutaneous closure of patent foramen ovale for cryptogenic stroke.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2021-07-05
Completion Date
2026-03-03
Last Updated
2026-10-22
Healthy Volunteers
No
Interventions
Implantation of Holter device
Implantation of a Holter device (Reveal Linq, Medtronic) for telemonitoring of cardiac rhythm
Percutaneous PFO closure
Patients will undergo percutaneous closure of patent foramen ovale
Locations (4)
University Hospital Besancon
Besançon, France
CHU Lyon - Hôpital Louis Pradel
Bron, France
CHU Dijon
Dijon, France
CHU Grenoble
Grenoble, France